Literature DB >> 24076439

Impact of genetic polymorphisms in base excision repair genes on the risk of breast cancer in a Korean population.

Kyoung-Yeon Kim1, Wonshik Han, Dong-Young Noh, Daehee Kang, Kyubum Kwack.   

Abstract

The contribution of single nucleotide polymorphisms (SNPs) in base excision repair (BER) genes to the risk of breast cancer (BC) was evaluated by focusing on two key genes: apurinic/apyrimidinic endonuclease 1 (APEX1) and 8-oxoguanine DNA glycosylase (OGG1). Genetic variations in the genes encoding these DNA repair enzymes may alter their functions and increase susceptibility to carcinogenesis. The aim of this study was to analyze polymorphisms in two BER genes, exploring their associations and particularly the combined effects of these variants on BC risk in a Korean population. Three SNPs of two BER genes were genotyped using the Illumina GoldenGate™ method. In total, 346 BC patients and 361 cancer-free controls were genotyped for these BER gene polymorphisms and analyzed for their correlation with BC risk in multiple logistic regression models. Multiple logistic regression models adjusted for age, family history of BC, and body mass index were used. The APEX1 Asp148Glu polymorphism was weakly associated with BC risk. The combined analysis among the BER genes, however, showed significant effects on BC risk. The APEX1 Asp148Glu carrier, in combination with OGG1 rs2072668 and OGG1 Ser326Cys, was strongly associated with an increased risk of BC. Moreover, the combination of the C-C haplotype of OGG1 with the APEX1 Asp148Glu genotype was also associated with an additive risk effect of BC [ORs=2.44, 2.87, and 3.50, respectively]. The combined effect of APEX1 Asp148Glu was found to be associated with an increased risk of BC. These results suggest that the combined effect of different SNPs within BER genes may be useful in predicting BC risk.
© 2013.

Entities:  

Keywords:  8-oxoguanine DNA glycosylase; 95% CI; 95% confidence interval; AP; APEX nuclease (multifunctional DNA repair enzyme) 1; APEX1; BC; BER; BMI; Base excision repair; Breast cancer; Gene–gene interaction; LD; MAF; OGG1; OR; Polymorphism; SNP; apurinic/apyrimidinic; base excision repair; body mass index; breast cancer; linkage disequilibrium; minor allele frequency; odds ratio; single nucleotide polymorphism

Mesh:

Substances:

Year:  2013        PMID: 24076439     DOI: 10.1016/j.gene.2013.09.069

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  12 in total

1.  The association between the APE1 Asp148Glu polymorphism and breast cancer susceptibility: a meta-analysis based on case-control studies.

Authors:  Zhiyong Zhao; Chuan Liu; Yong Zeng; Lei Gu; Mingzhen Ying; Ning Wang; Bin Hao; Huiyan Yao; Changqing Su; Yajie Wang; Yuchen Ma
Journal:  Tumour Biol       Date:  2014-01-14

2.  The hOGG1 Ser326Cys Gene Polymorphism and Breast Cancer Risk in Saudi Population.

Authors:  Mohammed Alanazi; Akbar Ali Khan Pathan; Jilani P Shaik; Abdullah Alhadheq; Zahid Khan; Wajahatullah Khan; Abdulrahman Al Naeem; Narasimha Reddy Parine
Journal:  Pathol Oncol Res       Date:  2016-11-07       Impact factor: 3.201

Review 3.  Polymorphisms in base excision repair genes: Breast cancer risk and individual radiosensitivity.

Authors:  Clarice Patrono; Silvia Sterpone; Antonella Testa; Renata Cozzi
Journal:  World J Clin Oncol       Date:  2014-12-10

4.  DNA Base-Excision Repair Genes OGG1 and NTH1 in Brazilian Lung Cancer Patients.

Authors:  Patricia G Couto; Luciana Bastos-Rodrigues; Juliana G Carneiro; Fernanda Guieiro; Maria Aparecida Bicalho; Franciele B Leidenz; Ana J Bicalho; Eitan Friedman; Luiz De Marco
Journal:  Mol Diagn Ther       Date:  2015-12       Impact factor: 4.074

5.  OGG1 Mutations and Risk of Female Breast Cancer: Meta-Analysis and Experimental Data.

Authors:  Kashif Ali; Ishrat Mahjabeen; Maimoona Sabir; Humera Mehmood; Mahmood Akhtar Kayani
Journal:  Dis Markers       Date:  2015-05-19       Impact factor: 3.434

Review 6.  Association between OGG1 Ser326Cys and APEX1 Asp148Glu polymorphisms and breast cancer risk: a meta-analysis.

Authors:  Qiliu Peng; Yu Lu; Xianjun Lao; Zhiping Chen; Ruolin Li; Jingzhe Sui; Xue Qin; Shan Li
Journal:  Diagn Pathol       Date:  2014-06-03       Impact factor: 2.644

Review 7.  XRCC1 and OGG1 Gene Polymorphisms and Breast Cancer: A Systematic Review of Literature.

Authors:  Ali Sanjari Moghaddam; Milad Nazarzadeh; Rezvan Noroozi; Hossein Darvish; Alireza Mosavi Jarrahi
Journal:  Iran J Cancer Prev       Date:  2016-02-23

8.  Association between the OGG1 Ser326Cys Polymorphism and Cancer Risk: Evidence from 152 Case-Control Studies.

Authors:  Hua Zou; Qing Li; Wei Xia; Yong Liu; Xi Wei; Dong Wang
Journal:  J Cancer       Date:  2016-06-23       Impact factor: 4.207

9.  Lack of any Association between the Hogg1 Ser326Cys Polymorphism and Breast Cancer Risk: a Systematic Review And Meta-Analysis Of 18 Studies

Authors:  Mahdieh Kamali; Saeed Kargar; Naeimeh Heiranizadeh; Mohammad Zare; Shadi Kargar; Masoud Zare Shehneh; Hossein Neamatzadeh
Journal:  Asian Pac J Cancer Prev       Date:  2017-01-01

10.  A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients.

Authors:  Petra Seibold; Peter Schmezer; Sabine Behrens; Kyriaki Michailidou; Manjeet K Bolla; Qin Wang; Dieter Flesch-Janys; Heli Nevanlinna; Rainer Fagerholm; Kristiina Aittomäki; Carl Blomqvist; Sara Margolin; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Diether Lambrechts; Hans Wildiers; Vessela Kristensen; Grethe Grenaker Alnæs; Silje Nord; Anne-Lise Borresen-Dale; Maartje J Hooning; Antoinette Hollestelle; Agnes Jager; Caroline Seynaeve; Jingmei Li; Jianjun Liu; Keith Humphreys; Alison M Dunning; Valerie Rhenius; Mitul Shah; Maria Kabisch; Diana Torres; Hans-Ulrich Ulmer; Ute Hamann; Joellen M Schildkraut; Kristen S Purrington; Fergus J Couch; Per Hall; Paul Pharoah; Doug F Easton; Marjanka K Schmidt; Jenny Chang-Claude; Odilia Popanda
Journal:  BMC Cancer       Date:  2015-12-16       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.